オプションチェーンは、Playa Hotels & Resortsの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Playa Hotels & Resortsの市場センチメントを評価します。.

Playa Hotels & Resorts (NASDAQ:PLYA) 株価情報, オプションチェーン

Playa Hotels & Resorts

Playa Hotels & Resorts NV acts as an owner, operator, and developer of all-inclusive resorts in prime beachfront locations in popular vacation destinations in Mexico and the Caribbean. The company's segments are Yucatan Peninsula, Pacific Coast, Dominican Republic, and Jamaica. It generates a majority of its revenue from the Yucatan Peninsula segment. Its brand profile consists of HYATT ZIVA, HYATT ZILARA, Hilton, JEWEL RESORTS, and others.

Playa Hotels & Resorts N.V. - Ordinary Shares

Playa Hotels & Resorts NV

Barclays analyst Tim Long maintains Harmonic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) with a Equal-Weight and lowers the price target from $14 to $10.

News

Price Target

Analyst Ratings

HLIT

Barclays Maintains Equal-Weight on Harmonic, Lowers Price Target to $10

Contracts

ESEA

Euroseas Announces 2-Year Charter Contract Extension For Feeder Containership, M/V EM Hydra; For Minimum Period Of 24 Months And Maximum Period Of 26 Months At Gross Daily Rate Of $19,000

B of A Securities analyst Michael Cherny maintains Progyny (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGNY#NASDAQ">PGNY</a>) with a Buy and raises the price target from $21 to $25.

PGNY

B of A Securities Maintains Buy on Progyny, Raises Price Target to $25

B of A Securities analyst Salvator Tiano maintains Archer-Daniels Midland (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADM#NYSE">ADM</a>) with a Underperform and lowers the price target from $54 to $48.

B of A Securities Maintains Underperform on Archer-Daniels Midland, Lowers Price Target to $48

Results demonstrate that CELZ-201 achieved an 80% overall efficacy rate in reducing insulin dependency and stabilizing hemoglobin A1c levels, with no serious adverse effects reported.

Biotech

General

CELZ

Creative Medical Technology Reports One-Year Results For AlloStem Type 2 Diabetes Program

Macro Economic Events

Economics

Federal Reserve

Fed's Hammack Says Will Evaluate Trump Economic And Trade Policies As They Come In

Barclays analyst Dan Levy maintains BorgWarner (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWA#NYSE">BWA</a>) with a Overweight and lowers the price target from $43 to $42.

Barclays Maintains Overweight on BorgWarner, Lowers Price Target to $42

B of A Securities analyst Steve Byrne maintains Corteva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTVA#NYSE">CTVA</a>) with a Buy and raises the price target from $69 to $73.

CTVA

B of A Securities Maintains Buy on Corteva, Raises Price Target to $73

As of Feb. 11, 2025, two stocks in the real estate sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Zillow Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZG#NASDAQ">ZG</a>)</h3>
<ul>
<li>On Feb. 5, Benchmark analyst Daniel Kurnos maintained Zillow with a Buy and raised the price target from $80 to $100. The company's stock gained around 25% over the past month and has a <a href="https://www.benzinga.com/quote/ZG">52-week high of $85.89</a>.</li>
<li>RSI Value: 75&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>ZG Price Action: Shares of Zillow gained 1% to close at $85.29 on Monday.</li>
</ul>
<h3 class="wp-block-heading">Welltower Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WELL#NYSE">WELL</a>)</h3>
<ul>
<li>On Jan. 29, NorthStar Healthcare Income, Inc. agreed to be acquired by an affiliate of Welltower for $3.03 per share in a $900 million transaction. Nikhil Chaudhri, Co-President and Chief Investment Officer of Welltower said, &#8220;We are delighted to have reached an agreement to acquire NorthStar&#8217;s portfolio of 40 seniors housing communities, which portfolio, subject to satisfaction of closing conditions and closing under the merger agreement, Welltower anticipates will be allocated to an entity affiliated with its recently announced funds management business." The company's stock gained around 14% over the past month and <a href="https://www.benzinga.com/quote/WELL">has a 52-week high</a> of $143.84.</li>
<li>RSI Value: 70.8</li>
<li>WELL Price Action: Shares of Welltower gained 0.4% to close at $143.11 on Monday.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43593480/wall-streets-most-accurate-analysts-give-their-take-on-3-real-estate-stocks-with-over-6-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Real Estate Stocks With Over 6% Dividend Yields</a></li>
</ul>

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

WELL

Top 2 Real Estate Stocks You May Want To Dump In February

WIIM

WESCO shares are trading lower following a Q4 EPS miss.

Rockwell Automation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>) reported better-than-expected first-quarter <a href="https://www.benzinga.com/quote/ROK/earnings">earnings on Monday</a>.
Sales fell 8.4% year over year and slid 7.6% organically to $1.881 billion, in line with the consensus of $1.881 billion. Total ARR grew 11%. Adjusted EPS was $1.83 (-10% YoY), above the analyst consensus of $1.59.
"From a demand perspective, we are encouraged by better-than-expected order performance in the quarter with sequential growth across all regions and business segments. While there is still some macroeconomic and policy uncertainty weighing on customers&#8217; capex plans, Rockwell won multi-million dollar strategic orders across key industries, especially in the U.S., our home market," commented Blake Moret, Chairman and CEO.
Rockwell Automation shares gained 12.7% to close at $302.34 on Monday.
These analysts made changes to their price targets on Rockwell Automation following earnings announcement.
<ul>
<li>Citigroup analyst Andrew Kaplowitz maintained Rockwell Automation with a Buy and raised the price target from $345 to $350.</li>
<li>Wells Fargo analyst Joseph O&#8217;Dea maintained the stock with an Overweight and raised the price target from $315 to $337.</li>
<li>Baird analyst Richard Eastman maintained the stock with an Outperform and raised the price target from $305 to $315.</li>
<li>Oppenheimer analyst Noah Kaye maintained Rockwell Automation with an Outperform and raised the price target from $300 to $320.</li>
</ul>
Considering buying ROK stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="589" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11091647/image-2-26-1024x589.png" alt="" class="wp-image-776671" style="width:506px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11091647/image-2-26-1024x589.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11091647/image-2-26-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11091647/image-2-26-768x441.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11091647/image-2-26.png 1122w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43592071/top-3-tech-stocks-that-may-jump-this-month">Top 3 Tech Stocks That May Jump This Mon</a>th</li>
</ul>

Earnings

Rockwell Automation Analysts Increase Their Forecasts After Upbeat Earnings

<a href="https://shareholder.ford.com/Investors/events/event-details/2025/Farley-House-to-Participate-in-the-Wolfe-Research-Auto-Auto-Tech-and-Semiconductor-Conference/default.aspx" title="https://shareholder.ford.com/Investors/events/event-details/2025/Farley-House-to-Participate-in-the-Wolfe-Research-Auto-Auto-Tech-and-Semiconductor-Conference/default.aspx">https://shareholder.ford.com/Investors/events/event-details/2025/Farley-House-to-Participate-in-the-Wolfe-Research-Auto-Auto-Tech-and-Semiconductor-Conference/default.aspx</a>

Government

Regulations

Ford CFO Says Considering Where To Build Inventory To Prepare For Mexico And Canada Tariffs; Ford Gets Most Of Its Aluminum And Steel From U.S, Sources

<ul>
<li>SMCI</li>
<li>TSLA</li>
<li>NVDA</li>
<li>PLTR</li>
<li>GOOGL</li>
<li>ACHR</li>
<li>GLD</li>
<li>AAPl</li>
<li>META</li>
<li>AMD</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

AAPL

ACHR

GOOGL

NVDA

PLTR

SMCI

TSLA

Top 10 Trending Stocks On WallStreetBets As Of February 11, 2025 (Via Swaggy Stocks)

Barclays analyst Andrew Lazar maintains Hain Celestial Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAIN#NASDAQ">HAIN</a>) with a Equal-Weight and lowers the price target from $6 to $5.

HAIN

Barclays Maintains Equal-Weight on Hain Celestial Group, Lowers Price Target to $5

Barclays analyst Lauren Lieberman maintains Edgewell Personal Care (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPC#NYSE">EPC</a>) with a Equal-Weight and lowers the price target from $33 to $30.

Barclays Maintains Equal-Weight on Edgewell Personal Care, Lowers Price Target to $30

ORMP

Oramed Announces Entered Into Definitive Agremeents To Spin Off Protein Oral Delivery Technology Into Joint Venture With Hefei Tianhui Biotech

Management

Tejon Ranch Appoints Matthew Walker As President & CEO; Succeeds Gregory S. Bielli

S&amp;P Global Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>) shares are trading higher<a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener"> in the premarket session on Tuesday.</a>
The company reported <a target="_blank" href="https://s29.q4cdn.com/690959130/files/doc_financials/2024/q4/S-P-Global-4Q-and-Full-Year-2024-Earnings-Release-Exhibits-2-11-2025.pdf" rel="noreferrer noopener">fourth-quarter</a> adjusted earnings per share of $3.77, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n43619727/s-p-global-reports-fourth-quarter-and-full-year-2024-results" rel="noreferrer noopener">beating the street view of $3.48</a>. Quarterly sales of $3.592 billion (+14%) outpaced the analyst consensus estimate of $3.503 billion, driven by growth in all divisions. Revenue from subscription products increased 6%.
The company said it successfully executed its leadership transition, with Martina Cheung assuming the role of President and CEO on November 1, 2024.
&#8220;As S&amp;P Global&#8217;s new CEO, I have had hundreds of conversations with our customers and partners, who have reinforced the need for our benchmarks, data, and insights to guide their decisions in a constantly evolving market,&#8221; Cheung added.
Adjusted operating profit margin increased 260 basis points to 46.7%, primarily due to strength in the Ratings unit.
Also Read:<a target="_blank" href="https://www.benzinga.com/25/02/43621782/insurance-giant-humanas-q4-earnings-at-par-with-estimates-2025-profit-outlook-falls-below-street-view" rel="noreferrer noopener"> Insurance Giant Humana&#8217;s Q4 Earnings: 13% Revenue Growth, 2025 Profit Outlook Falls Below Street View</a>
The company exited the quarter with cash and equivalents worth $1.66 billion.
Long-term debt as of quarter end totaled $11.394 billion.
S&amp;P Global recently authorized a quarterly <a target="_blank" href="https://www.benzinga.com//node/43286805" rel="noreferrer noopener">cash dividend of $0.96</a>, marking the company&#8217;s 52nd consecutive year of dividend increases. Additionally, the Board has authorized the repurchase of shares totaling up to $4.3 billion. The company expects to launch an initial $650 million Accelerated Share Repurchase in the coming weeks.
Outlook: For the full year 2025, S&amp;P Global maintains its target of returning 85% or more of adjusted free cash flow to shareholders through dividends and share repurchases.
The company projects FY25 revenue growth of 5% &#8211; 7%, along with adjusted EPS in the range of $17.00 to $17.25. This guidance is <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">above the $16.92 estimate.</a>
S&amp;P Global expects 2025 cash provided by operating activities, less capital expenditures and distributions to noncontrolling interest holders, of ~$5.9 billion. It expects adjusted free cash flow, excluding certain items, of $6 billion.
Price Action: SPGI shares are trading higher by 5.96% to $546.00 premarket at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/02/43604305/what-to-expect-when-biotech-giant-gilead-reports-q4-earnings-on-tuesday" target="_blank" rel="noreferrer noopener">What To Expect When Biotech Giant Gilead Reports Q4 Earnings On Tuesday?</a></li>
</ul>
Photo via Shutterstock.

Equities

Large Cap

Guidance

Dividends

Buybacks

Movers

SPGI

S&P Global's Ratings Power Q4 Surge, Capital Returns Sweeten The Deal

Events

TLSA

Tiziana Life Sciences Formulab Featured On News Channel

Keybanc analyst Eric Gonzalez maintains McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) with a Overweight and raises the price target from $320 to $335.

Keybanc Maintains Overweight on McDonald's, Raises Price Target to $335

Playa Hotels & Resorts (PLYA) previously announced it had entered into an exclusivity agreement with Hyatt Hotels (H) regarding discussions between...

Playa Hotels & Resorts extends exclusivity period with Hyatt

Hyatt Hotels (H) announced it has extended its previously disclosed exclusivity agreement date with Playa Hotels & Resorts (PLYA), under which Play...

Hyatt extends exclusivity agreement date with Playa Hotels & Resorts

At closing, Hyatt (H) expects to fund 100% of the acquisition with new debt financing and, consistent with maintaining its investment grade profile...

Hyatt to fund 100% of Playa acquisition with new debt financing

07:02 EST Playa Hotels & Resorts to be acquired by Hyatt (H) for $13.50 per share in cash Published first on TheFly – the ultimate source for real-...

Playa Hotels & Resorts to be acquired by Hyatt for $13.50 per share in cash

Hyatt Hotels to acquire resort operator Playa for ~$2.6B

Check out this morning's top movers from around Wall Street, compiled by The Fly. HIGHER – Axsome Therapeutics (AXSM) up 15% after entering into a ...

Morning Movers: Aluminum, steel stocks gain on planned 25% tariffs on imports

Macquarie analyst Chad Beynon downgraded Playa Hotels & Resorts (PLYA) to Neutral from Outperform with a price target of $13.50, down from $16 afte...

Playa Hotels & Resorts downgraded to Neutral from Outperform at Macquarie

Oppenheimer analyst Tyler Batory downgraded Playa Hotels & Resorts (PLYA) to Perform from Outperform without a price target after the company enter...

Playa Hotels & Resorts downgraded to Perform from Outperform at Oppenheimer

Hyatt Hotels' deal for Playa is seen being 'highly productive and accretive' over time

Deutsche Bank downgraded Playa Hotels & Resorts (PLYA) to Hold from Buy with a price target of $13.50, down from $15, after the company entered int...

Comments

Playa Hotels & Resorts

Playa Hotels & Resorts (PLYA) オプション

Playa Hotels & Resorts (NASDAQ:PLYA) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル